Logo

People in the News: R. Weslie Tyson, Richard Hockett

Mar 13, 2014
Premium

CombiMatrix has hired pediatric pathologist R. Weslie Tyson as its new chief medical officer. Tyson will join his new post on April 8 and report to CEO Mark McDonough. He will replace Richard Hockett who previously served as the company's chief medical officer.

Tyson, a pediatric and perinatal pathologist for more than two decades, comes to CombiMatrix from UniPath, a pathology group that serves several hospitals and labs. There, he founded the pediatric/neonatology section and was in charge of pediatric and perinatal services since 1999.

Filed under

Diagnostics
Invitae
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.